Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Characterization of Compensatory Stepping in People with Multiple Sclerosis.
Efficacy and safety of onabotulinumtoxinA therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: Final results of a long-term extension study.
Recovery from an acute relapse is associated with changes in motor resting-state connectivity in multiple sclerosis.
Intracerebroventricular injection of lipopolysaccharide increases gene expression of connexin32 gap junction in rat hippocampus.
An unusual case of 'itchy paralysis': neuromyelitis optica presenting with severe neuropathic itch.
Antibody patterns vary arbitrarily between cerebrospinal fluid and aqueous humor of the individual multiple sclerosis patient: Specificity-independent pathological B cell function.
Long-term safety of fingolimod: Interim evaluation of data from the longterms trial.
Role of cytokines in multiple sclerosis and experimental autoimmune encephalomyelitis.
Commentary: Inflammation, Demyelination and Neurodegeneration: Risky Buddies in Multiple Sclerosis.
Immunization of mice with a peptide derived from the HTLV-1 TAX1BP1 protein induces cross-reactive antibodies against aquaporin 4.
White matter integrity in polydrug users in relation to attachment and personality: a controlled diffusion tensor imaging study.
Methylprednisolone induced liver injury: Case report and literature review.
A proposed dosing algorithm for the individualized dosing of human immunoglobulin in chronic inflammatory neuropathies.
Paraneoplastic isaacs' syndrome: a case series and review of the literature.
Adrenomedullin promotes differentiation of oligodendrocyte precursor cells into myelin-basic-protein expressing oligodendrocytes under pathological conditions in vitro.
Impact of MS genetic loci on familial aggregation, clinical phenotype, and disease prediction.
Neuroprotective Effects of Endurance Exercise against High Fat Diet-Induced Hippocampal Neuroinflammation.
The Neuroprotective Effect of the Association of Aquaporin-4/Glutamate Transporter-1 against Alzheimer's Disease.
A previously misdiagnosed cohort of aquaporin 4 antibody-positive neuromyelitis optica spectrum disorder with disease duration of >10 years in multi-ethnic Penang, Malaysia: Clinical features and disease course.
Monocyte chemoattractant protein-1 promoter -2518 polymorphism and susceptibility to vasculitis, rheumatoid arthritis, and multiple sclerosis: A meta-analysis.
Tysabri® (natalizumab) data at ECTRIMS reaffirm positive effects of treatment for people with relapsing forms of MS
Cytokines and chemokines in neuromyelitis optica: pathogenetic and therapeutic implications.
Late-onset neuromyelitis optica spectrum disorder in AQP4-seropositivepatients in a Chinese population.
Microglia-blood vessel interactions: a double-edged sword in brain pathologies.
Guillain Barré Syndrome in a multiple myeloma patient after the first course of bortezomib therapy: A case report.

Pages